Current Issue

Volume: 45 Issue: 4 , 12/1/25

Year: 2025

Research Article

Review

Hacettepe University Journal of the Faculty of Pharmacy has been published regularly twice in a year since 1981 till 2021.We have been publishing 4 issues a year since 2021. In our journal, we publish recent studies on Pharmaceutical Toxicology, Pharmaceutical Chemistry, Social Pharmacy, Pharmacognosy, Pharmaceutical Botany, Pharmaceutical Technology, Pharmaceutical Biotechnology, Radiopharmacy, Analytical Chemistry, Biochemistry, Pharmaceutical Microbiology, Basic Pharmaceutical Sciences, Pharmacology and also topics related with the pharmaceutical area.
All manuscripts are subject to rapid peer review and those of high quality (not previously published and not under consideration for publication in another journal) are published without delay.
It is obligatory to comply with Research and Publication Ethics in articles.
Hacettepe University Journal of the Faculty of Pharmacy publishes original research artricles and review articles. Both type articles should be written in English.
The journal is an open access peer refereed scientific journal.
We have no purpose of profit and no publication fees.

In our journal, we publish recent studies on Pharmaceutical Toxicology, Pharmaceutical Chemistry, Social Pharmacy, Pharmacognosy, Pharmaceutical Botany, Pharmaceutical Technology, Pharmaceutical Biotechnology, Radiopharmacy, Analytical Chemistry, Biochemistry,  Pharmaceutical Microbiology, Basic Pharmaceutical Sciences, Pharmacology and also topics outside the pharmaceutical area.

Hacettepe University Journal of the Faculty of Pharmacy  publishes original research artricles and review articles.

Both type articles should be written in English.

1. All manuscripts must be in MS Word format and should be submitted via our online submission system.  Authors are encouraged to use the manuscript main text template provided in our website to prepare their manuscripts. Title page and main text of the manuscrip should be uploaded on seperate word files to the system. Title page must contain the title, authors names, ORCİD numbers, affiliations and corresponding author information. Corresponding author name, affiliation, address, e-mail and telephone number must also be included. The manuscript must be consist of title, abstract, keywords (minimum 3, maximum 5) and the rest of the manuscript.

2The manuscript should be prepared as a single wod file including Title, Abstact and Keywords, Main Text, Acknowledgements, Conflict of Interest, Statament of Contribution of Researchers, References. Figures, Schemas and Tables must be embedded to the main text.

The full names, addresses and ORCİD numbers of all authors, in addition, e-mail address and telephone number of the corresponding author must be provided with the title page only as a seperate file. Authors should indicate their information with the title page but not with the manuscript.

3. Each manuscript should be accompanied by a cover letter addressed to the Editor and signed by the corresponding author on behalf of all authors. The cover letter should explicitly state that the manuscript has not been previously published in another language anywhere, and that it is not under simultaneous consideration by another journal. This journal does not accept manuscripts that are simultaneously being considered by another journal or already published elsewhere. Thus, authors are required to include the following statement in the Cover Letter:

"This manuscript has not been previously published in another language anywhere and that it is not under simultaneous consideration by another journal."
Authors may submit the names, affiliations and addresses (including e-mail) of at least three expert reviewers or those they do not want to review their papers.

4. Authors would be required to sign a transferring copyright form which will be supplied by the Editor, to our journal after the manuscript is accepted for publication.

5. Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee in accordance with "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985) and/or the declaration of Helsinki promulgated in 1964 as amended in 1996. The method section must include a statement to prove that Ethical aspects of the investigation was approved and that informed consent was obtained. The board name, date and protocol number of the approval of ethical commission must be given in two sections as “Material and Method” and “Conclusion” parts.

 STRUCTURE:

1. Manuscripts must be neatly typed with “Times New Roman 12 pt” (size page A4), double-spaced throughout, including figures and tables, with 2.5 cm margins on all sides.
2. The Editor reserves the right to adjust style to certain standards of uniformity. Every page of the manuscript must be numbered at the right top.
3. Titles and subtitles should be written bold and title case. Subheadings must be in ithalic form. Subheadings above 3rd degree are not allowed.
4. The usage of italics should be limited to scientific names of organisms.
5. Mention the full form of abbreviations when they appear for the first time in the text.
6. References need to be cited in the text inside the brackets. (Example: Analysis of NS [1] was performed by spectrophotometric and electrochemical methods [2-6].)
7.Figures, Schemas and Tables must be cited in the text if they exist.  

ARTICLE TYPES:

Hacettepe University Faculty of Pharmacy Journal accept submission of research articles and review written in English. Manuscripts should be prepared according to the mentioned guidelines, reference limitations and other related information.

 Research articles

1. Manuscript should include adequate information for reproducibility by specialists.
2. The manuscript should be prepared as a single wod file including Title, Abstact and Keywords, Main Text, Acknowledgements, Conflict of Interest, Statament of Contribution of Researchers, References. Figures, Schemas and Tables must be embedded to the main text.
3. The title should not include abbreviations except well known abbreviations such as HPLC, DNA, etc. The title should not exceed 15 words. Abstract should not exceed 200 words, and minimum 3, maximum 5 keywords must be given related to the manuscript.
4. The full names and addresses of all authors, in addition, e-mail address and telephone number of the corresponding author must be provided with the title page only.
5. Second page should start with the Introduction. The other sections should be Materials and Methods, Results and Discussion, Conclusion, Acknowledgements (if necessary), Conflict of Interest Statement, Contribution of Researchers and References.
6. Figures and Tables must be presented where they are mentioned in the text.
7. Sections ranging from the Introduction to the Conclusions should be numbered with Arabic numerals such as 1, 2, etc. Subheadings should also be numbered with Arabic numerals such as 1.1, 1.2, 2.1, 2.2, etc. Titles and subtitles should be written bold and title case. Subheadings must be in ithalic form. Subheadings above 3rd degree are not allowed. All pages should be numbered consecutively, the title page being p.1.

Review articles

1. Highly focused review articles written by experts on the relevant subjects will be published.
2. The manuscript should be prepared as a single wod file including Title, Abstact and Keywords, Main Text, Acknowledgements, Conflict of Interest, Statament of Contribution of Researchers, References. Figures, Schemas and Tables must be embedded to the main text.
3. The title should not include abbreviations except well known abbreviations such as HPLC, DNA, etc. The title should not exceed 15 words. Abstract should not exceed 200 words, and minimum 3, maximum 5 keywords must be given related to the manuscript.
4. The full names and addresses of all authors, in addition, e-mail address and telephone number of the corresponding author must be provided with the title page only.
5. Figures and Tables must be presented where they are mentioned in the text.
6. Sections ranging from the Introduction to the Conclusions should be numbered with Arabic numerals such as 1, 2, etc. Sub-headings should also be numbered with Arabic numerals such as 1.1, 1.2, 2.1, 2.2, etc. Subheadings must be in ithalic form. Subheadings above 3rd degree are not allowed. All pages should be numbered consecutively, the title page being p.1.
7. A review article should consists of Introduction, relevant headings/subheadings and Conclusion sections. All headings and subheadings should be numbered with Arabic numerals as described in Research Articles section. The number of references is limited to 100.


Figures :
Authors are responsible for managing the inclusion of third-party content as an author/editor of a work. We refer to 'third party content' as any work that authors haven't developed themselves and have copied or adapted from other sources. Figures, photographs, tables, screenshots, and other items may be included.

Unless the figure is in the public domain (copyright-free) or permitted for use under a Creative Commons or other open licenses, the author must get permission from the copyright holder(s).
Published/reproduced material should not be included unless written permission has been obtained from the copyright holder, which should be forwarded to us.
It should also be stated below Figure as:
Reprinted from Publication title, Volume /edition number, Author(s), Title of article / title of chapter, Pages No., Copyright (Year), with permission from [NAME OF PUBLISHER OR APPLICABLE SOCIETY COPYRIGHT OWNER].



References 
Vancouver Style should be used for reference writing
• References are listed in numerical order, and in the same order in which they are cited in text. The reference list appears at the end of the paper.
• Begin your reference list on a new page and title it 'References'.
• The reference list should include all and only those references you have cited in the text. (However, do not include unpublished items)
• Use Arabic numerals (1, 2, 3, 4, 5, 6, 7, 8, 9)
Abbreviate journal titles in the style used in the web of science.
• Check the reference details against the actual source
• The preferred method is to list each reference number separated by a comma, or by a dash for a sequence of consecutive numbers. There should be no spaces between commas or dashes
Provide doi for all references at the end of each reference.
(ex: https://doi.org/10.1142/9789814324496xxxx).
• The in-text citation is placed immediately after the text which refers to the source being cited using square brackets [1].

Journal:
Author. Title|. Journal. Year;Volume(Issue):Pages.
1. Egger F, Jakab M, Fuchs J, Oberascher K, Brachtl G, Ritter M, et al. Effect of glycine on BV-2 microglial cells treated with interferon-gamma and lipopolysaccharide. Int J Mol Sci. 2020;21(3):804-10. https://doi.org/10.1142/9789814324496_xxxx

Book:
2. Author. Title. Edition ed. Series Editor,Place Published: Publisher; Year Date. Number of Pages p
Upton R. American Herbal Pharmacopoeia: botanical pharmacognosy-microscopic characterization of botanical medicines. Boca Raton, FL: American Herbal Pharmacopoeia/CRC Press; 2011. 773 p.

3. Author. Title. In: Editor, Book Title. Series Title. Volume. Edition eds. Place Published: Publisher; Year. p. Pages.
Kayaalp SO. Estrojenler, Projestinler ve Antagonistleri. In: Kayaalp SO, editor. Rasyonel Tedavi Yönünden Tıbbi Farmakoloji. Ankara: Hacettepe-Taş; 2005. p. 1164-77.

Proceeding or Abstract:
4. Author. Title. In: Editor, Conference Name; Date; Conference Location. Place Published: Publisher; Year. p. Pages.
Uyar B, Celebier M, Altinoz S. Determination of Rosuvastatin Calcium in Pharmaceutical Preparations by UV-Visible Spectrophotometric Method. 8th International Symposium on Pharmaceutical Sciences ISOPS–8; 13-16 June 2006; Ankara-Turkey; Ankara, 2006.

Web Page:
5. Author. Title. Place Published: Publisher; Year; [Year Cited Date Cited]. Contents; Edition: [Description]. Available from:Availab≤om: URL.
WHO. Coronavirus disease (COVID-19) pandemic. 2021. [cited May 2023]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 .

NOMENCLATURE, SYMBOLS, UNITS:
1- Use only SI quantities and units (SI = Système International d’Unités). All nomenclature should follow established rules wherever these are available.
2- Only generic and chemical names of drugs should be used, although a proprietary equivalent may be indicated once, in parentheses. Pharmacological and Chemical Synonyms, E.E.J. Marler, 9th edn. (Elsevier, Amsterdam, 1990) may be consulted.
3- The nomenclature of chemical substances should be consistent, clear and unambiguous, and should conform to the usage of the American Chemical Society and the convention recommended by the International Union of Pure and Applied Chemistry (IUPAC). When in doubt, writers should consult the indexes of Chemical Abstracts; the various reports and pamphlets of the American Chemical Society Committee on Nomenclature, Spelling and Pronunciation; and from the International Union of Biochemistry and Molecular Biology (IUBMB): Biochemical Nomenclature and Related Documents (Portland Press, London).
4- The trivial name of the enzyme may be used in the text, but the systematic name and classification number according to Enzyme Nomenclature, rev. edn. (Academic Press, New York, NY, 1984) should be quoted for the first time the enzyme is mentioned


Units of mass

kilogram kg

gram g

milligram mg

microgram μg

nanogram ng

mole (gram-molecule) mol

millimole mmol

micromole μmol

nanomole nmol

picomole pmol

equivalent eq

 

Units of time

Hour h

Minute min

Second s

Millisecond ms

Microsecond μs

 

Units of volume

1 litre L

Millilitre mL

Microlitre μL

 

Units of length

Metre m

Centimetre cm

Millimetre mm

Micrometre μm

Nanometre nm

 

Units of concentration

molar (mol/L) M

millimolar mM

micromolar μM

nanomolar nM

picomolar pM

 

Units of heat

Joule J

degree Celsius (centigrade) °C

coulomb C

ampere A

volt V

ohm Ω

Siemens S

 

Others

Curie Ci

Gravity g

dissociation constant Kd

median doses LD50, ED50

probability P

routes of drug administration i.v., i.p., s.c., i.m.

standard deviation SD

standard error of the mean SE

relative standard deviation RSD

MATHEMATICAL EQUATIONS:

Mathematical equations should be drawn or written in the manuscript at the appropriate places where they belong. They should always stand alone (i. e. occupy extra lines, Right sided, Equation 1).

X=…                                                                                                                                                               Equation 1

REVISED MANUSCRIPT

Revised manuscripts should be returned as follows:
• A revised text file with all alterations are clearly highlighted and visible should be submitted.
• Use either (1) the track change mode in Microsoft Word or (2) highligt the areas containing the required alterations.
• Responses to reviewer’s comments file (Word) must be submitted seperetaly summarizing how you have deal with each of the reviewers’ remarks.
• The file(s) with the changes visible on screen should be submitted to the online procedure. Upon acceptance of the manuscript the final uploaded version will be taken as the basis for copyediting and the subsequent production process. 


MANUSCRIPT SUBMISSION CHECK-LIST:

Please carefully go through the following check list. Non-compliance with Hacettepe University Journal of the Faculty of Pharmacy manuscript formatting requirements will result in the manuscript being returned to the corresponding author for reformatting or rejection.
[ ] Is the manuscript typed double-spaced with 2.5 cm of margins from all sides on A4 (MS Word 2003 or newer version) including all the sections? .Note that PDF is not acceptable.
[ ] Are the authors’ full names, affiliations and ORCID numbers given in ‘Title page’ but not in manuscript?
[ ] Is the Abstract written within the 200 word limit and 3 to 5 keywords provided?
[ ] Is there a ‘Conclusion’ section?
[ ] Is there an ethical approval stated in two sections? The board name, date and protocol number of the approval of ethical commission must be given in two sections as “Material and Method” and “Conclusion”.
[ ] Are there Acknowledgement, Conflict of Interest, Statament of Contribution of Researchers parts in the manuscript before references.
[ ] Is the reference numbering style within text co-script with square parenthesis (squared brackets) with the numbers inserted before and not after punctuations?
[ ] Does the ‘References' list adhere strictly to HUJPHARM format (Vancouver style)?
[ ] Do you abbrivate journal names as stated in reference writing?
[ ] Is there a legend/caption at the bottom of each Figure and at the top of each Table?
[ ] Are the Figures/images sharp and clear with legible fonts of at least font 12 for y- and x-axis labels, units and annotations?
[ ] Are the borders removed around the Figures?
[ ] Are Figures and Tables inserted at appropriate places in the manuscript nearest to where reference was made to them?

Publisher
Hacettepe University Journal of the Faculty of Pharmacy is published by Hacettepe University, Faculty of Pharmacy Ankara/Turkey.

Scope
Hacettepe University Journal of the Faculty of Pharmacy publish recent studies on Pharmaceutical Toxicology, Pharmaceutical Chemistry, Social Pharmacy, Pharmacognosy, Pharmaceutical Botany, Pharmaceutical Technology, Pharmaceutical Biotechnology, Radiopharmacy, Analytical Chemistry, Biochemistry, Pharmaceutical Microbiology, Basic Pharmaceutical Sciences, Pharmacology and also topics related with the pharmaceutical area.

Period
Quarterly (March, June, September and December)
Hacettepe University Journal of the Faculty of Pharmacy is a peer-reviewed academic journal which is published four times a year.

Review of Articles
Hacettepe University Journal of the Faculty of Pharmacy accepts paper submission from researchers .
Articles submitted to Hacettepe University Journal of the Faculty of Pharmacy are first reviewed by the Editors in terms of the journal's publishing principles and scope.
Those found unsuitable are returned to their authors for revision.
Submissions found suitable are referred to two referees working in relevant fields. The names of the referees are kept confidential and referee reports are archived by dergipark. If one of the referee reports is positive and the other is negative, the article may be forwarded to a third referee for further assessment or alternatively, the Editor may make a final decision based on the nature of the refrees' reports.
The authors are responsible for revising their articles in line with the criticism and suggestions made by the referees and the Editor. If they disagree with any issues, they may make an objection by providing clearly-stated reasons.

Language of Publication
The language of Hacettepe University Journal of the Faculty of Pharmacy is English.

Plagiarism Policy
All articles are checked by technical editor by means of a program (Ithenticate) in order to confirm they are not published before and avoid plagiarism.

Only Exclude Bibliography in settings and Exclude resources less than: 5 Words “Exclude sources that are less than: 5 words” settings should be used.
Studies with more than 30% similarity in the entire study as a result of the screening are not included in the preliminary evaluation.
The preliminary evaluation process of the articles that pass this examination is completed.

All responsibility for ethical violations belongs to the authors.

Open Access Policy
This journal provides immediate open access to its content based on the principle to make the research freely available to the public that supports a greater global exchange of knowledge.
Hacettepe University Journal of the Faculty of Pharmacy is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND)

Archiving
Each issue is archived by dergipark in https://dergipark.org.tr/tr/pub/hujpharm web adress. Since we are indexed in Scopus, it includes the articles in its system.

Processing Charges
Hacettepe University Journal of the Faculty of Pharmacy does not charge any article submission, processing charges, and printing charge from the authors.

Preparation and Submissions
Submission to this journal proceeds totally online, via submission page of HUJPHARM: https://dergipark.org.tr/tr/pub/hujpharm.

Submissions to Hacettepe University Journal of the Faculty of Pharmacy should be original articles evaluating previous studies in the field and should produce new and worthwhile ideas and perspectives

The manuscript should be submitted to the deripark system as two seperate files.

Manuscript should include Title, Abstract, Key Words, Main Text, Acknowledgements, Conflict of interest Statement, Contribution of Researchers, References. Figures and Tables must be presented where they are mentioned in the text.
Title page should include title of the manuscript, full names and the addresses of all authors, in addition, e-mail address and telephone number of the corresponding author must be provided with the title page only. Orcid numbers of all authors should be provided in the title page. Sumissions without orcid numbers will not be accepted for peer review.

Sections ranging from the Introduction to the Conclusions should be numbered with Arabic numerals such as 1, 2, etc. Subheadings should also be numbered with Arabic numerals such as 1.1, 1.2, 2.1, 2.2, etc. Subheadings above 3rd degree are not allowed.
Any subsection may be given a brief heading. Each heading should appear on its own separate line.
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Results and discussion should be clear and concise.
In terms of ethical approval; the board name, date and protocol number of the approval of ethical commission must be given in two sections as “Material and Method” and “Conclusion”.

Revised manuscripts should be returned as follows:
• A revised text file with all alterations are clearly highlighted and visible should be submitted.
• Use either (1) the track change mode in Microsoft Word or (2) highligt the areas containing the required alterations.
• Responses to reviewer’s comments file (Word) must be submitted seperetaly summarizing how you have deal with each of the reviewers’ remarks.
• The file(s) with the changes visible on screen should be submitted to the online procedure. Upon acceptance of the manuscript the final uploaded version will be taken as the basis for copyediting and the subsequent production process.
Non-compliance with Hacettepe University Journal of the Faculty of Pharmacy manuscript formatting requirements will result in the manuscript being returned to the corresponding author for reformatting or rejection.
An article to be published in Hacettepe University Journal of the Faculty of Pharmacy should not have been previously published or accepted for publication elsewhere.

Publication Policy:
Publication process at Hacettepe University Journal of the Faculty of Pharmacy is the basis of the improvement and dissemination of information objectively and respectfully. Therefore, the procedures in this process improve the quality of manuscripts.
Double blind peer-reviewed studies are the ones that support and materialize the scientific method. At this point, all parties included in the publication process (authors, readers and researchers, publisher, reviewers and editors) comply with the standards of ethical considerations. Hacettepe University Journal of the Faculty of Pharmacy expects all parties to hold the following ethical responsibilities.

It is obligatory to comply with Research and Publication Ethics in articles.

According to the decisions taken by the relevant boards of TÜBİTAK ULAKBİM TR DİZİN, from the authors of the articles other than the type of compilation to be applied for publication in all journals indexed in TR DİZİN and under evaluation;
• Indication and documentation of the ethics committee approval (The board name, date and protocol number of the approval of ethical commission must be given in “Material and Method”) and method section of the candidate article for research that requires data collection through methods such as scales, surveys, interviews, and observations,
• The information that the informed consent/consent form was signed,
• The proofs of attention to ethical principles in the data collection process (such as obtaining permission from others for the use of scales, questionnaires, documents) are presented,
• Research and publication ethics are compliance should be indicated in the articles.
The following ethical duties and responsibilities are written in the light of the guide and policies made by Committee on Publication Ethics (COPE).

The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, and the publisher.

1. Publication and authorship:
· List of references, financial support;
· No plagiarism, no fraudulent data;
· Forbidden to publish same research in more than one journal.

2. Author’s responsibilities:
· Authors obliged to participate in peer review process;
· All authors have significantly contributed to the research;
· Statement that all data in article are real and authentic;
· All authors are obliged to provide retractions or corrections of mistakes.

3. Peer review / responsibility for the reviewers:
· Judgments should be objective;
· Reviewers should have no conflict of interest with respect to the research, the authors and/or the research funders;
· Reviewers should point out relevant published work which is not yet cited;
· Reviewed articles should be treated confidentially.

4. Editorial responsibilities:
· Editors have complete responsibility and authority to reject/accept an article;
· Editors should have no conflict of interest with respect to articles they reject/accept;
· Only accept a paper when reasonably certain;
· When errors are found, promote publication of correction or retraction;
· Preserve anonymity of reviewers.
· No plagiarism, no fraudulent data.

5. Publishing ethics issues
· Monitoring/safeguarding publishing ethics by editorial board;
· Guidelines for retracting articles;
· Maintain the integrity of the academic record;
· Preclude business needs from compromising intellectual and ethical standards;
· Always be willing to publish corrections, clarifications, retractions and apologies when needed.

Duties of the Publisher
Hacettepe University Journal of the Faculty of Pharmacy is committed to ensure that commercial revenue has no impact or influence on editorial decisions. In addition, Hacettepe University Journal of the Faculty of Pharmacy will assist in communications with other journals and/or publishers where this is useful to editors. Finally, we are working closely with other publishers and industry associations to set standards for best practices on ethical matters, errors and retractions–and are prepared to provide specialized legal review and counsel if necessary.

Plagiarism Detection
Hacettepe University Journal of the Faculty of Pharmacy uses single-blind review fulfilled by at least two reviewers. In addition, all articles are checked by means of a program (Ithenticate) in order to confirm they are not published before and avoid plagiarism.

The peer review process is at the heart of the success of scientific publishing. As part of our commitment to the protection and enhancement of the peer review process, Hacettepe University Journal of the Faculty of Pharmacy has an obligation to assist the scientific community in all aspects of publishing ethics, especially in cases of (suspected) duplicate submission or plagiarism.

When a reader discovers a significant error or inaccuracy in a paper published in Hacettepe University Journal of the Faculty of Pharmacy or have any other complaint about editorial content (plagiarism, duplicate papers, etc.), he/she should make a complaint by e-mail to: ayseguleren@yahoo.com (primary contact)
Complaints are carefully considered as they provide an opportunity for improvement, and we aim to respond quickly and constructively.

Hacettepe University Journal of the Faculty of Pharmacy does not charge any article submission, processing charges, and printing charge from the authors. The journal is an open access peer refereed scientific journal. We have no purpose of profit and no publication fees.

Editor-in -Chief

Default avatar
Prof. Dr. Mutlu AYTEMİR HACETTEPE ÜNİVERSİTESİ
Pharmaceutical Chemistry

Vice Editors

Default avatar
Assoc. Prof. Ayşegül DOĞAN HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmacology and Pharmaceutical Sciences, Pharmaceutical Analytical Chemistry, Analytical Chemistry, Health Sciences
Default avatar
Assoc. Prof. Dr. Bilge SÖZEN ŞAHNE HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmacology and Pharmaceutical Sciences, Pharmacy Management

Advisory Board

Sibel A. ÖZKAN, 1986 yılından beri Ankara Üniversitesi Eczacılık Fakültesi'nde Analitik Kimya Profesörü olarak görev yapmaktadır.
Türkiye Kimya Derneği adına Avrupa Kimya Derneği-DAC üyesidir. Avrupa Farmakopesi-EDQM-Kromatografi Bölümü üyesidir. Ayrıca Uluslararası Elektrokimya Derneği (ISE) ve Amerikan Kimya Derneği (ACS) üyesidir.

COST Eylem Yönetim Komitesi: PortASAP: - Taşınabilir, uygun fiyatlı ve basit analitik platformların tanıtımı için Avrupa ağı: Cost Action CA 16215'in temel grubu. Çalışma Grubu 4. (2022'de tamamlandı).

COST Eylem Yönetim Komitesi: WATERTOP: - Kaynak ve içme suyu sorunlarının erken teşhisinde tat ve koku (WATERTOP) COST Eylem CA18225'in temel grubu - Çalışma Grubu 1 - Su T&O'nun duyusal analizinde ilerlemeler (2023'te tamamlandı).
COST Eylem Yönetim Komitesi: LUCES: - Çevresel Güvenlik için Supramoleküler Lüminesanslı Kemosensörler (LUCES) CA22131, (2024-Devam Ediyor). (MC Cair: Rodriguez Laura)

TÜBİTAK tarafından desteklenen 2 adet devam eden Üniversite-İlaç Sanayi Projesi bulunmaktadır. 2 adet HORIZON ve 1 adet ikili anlaşma projesi (Çin ile) bulunmaktadır.
LC yöntemleri, ayırma teknikleri, yeşil kimya, kiral ayırma, ilaç analizi, elektrokimyasal biyosensörler, nanosensörler, nanobiyosensörler, MIP sensörleri, DNA biyosensörleri, enzim biyosensörleri, biyobelirteçler, çevresel sensörler, yöntem geliştirme ve ilaç analizlerinin validasyonu ile ilgili çeşitli analitik kimya projelerinde yer almıştır.
500'den fazla orijinal ve derleme makalesi yayınlamış, h-indeksi 54'tür (ISI-WoS'de indekslenmiştir) ve 12 bilimsel kitabın ve yaklaşık 70 kitap bölümünün editörüdür.
Birçok uluslararası ve ulusal ödülü bulunmaktadır.

Journal of Pharmaceutical and Biomedical Analysis (SCI-Elsevier) dergisinin editörü, Essential Chem (Taylor&Francis) dergisinin Analitik ve Çevresel Bölüm Editörü ve Current Pharmaceutical Analysis (SCI-Bentham) dergisinin Avrupa Bölümü Editörüdür. Ayrıca, Talanta (SCI), Trends in Analytical Chemistry, Chromatographia (SCI), Biosensors & Bioelectronics X, Critical Reviews in Analytical Chemistry, Electrochimica Acta, Analytical & Bioanalytical Chemistry, Advanced Sample Prep., Green Analytical Chemistry vb. dergilerin Editör Kurulu üyesidir.

Pharmacology and Pharmaceutical Sciences, Pharmaceutical Analytical Chemistry, Sensor Technology
Default avatar
Prof. Dr. Ayhan SAVAŞER SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE SAĞLIK BİLİMLERİ ENSTİTÜSÜ, FARMASÖTİK TEKNOLOJİ ANABİLİM DALI
Pharmaceutical Delivery Technologies
Default avatar
Prof. Dr. Hande SİPAHİ YEDİTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmaceutical Sciences, Pharmaceutical Toxicology, Toxicology
Default avatar
Prof. Dr. Tahir SULEYMANOV Azerbaijan Medical University
Pharmaceutical Chemistry
Bezhan Chankvetadze
Prof. Dr. Bezhan CHANKVETADZE Tbilisi State University

Bezhan Chankvetadze is Full Professor for Physical Chemistry and director of the Institute of Physical and Analytical Chemistry at the Tbilisi State University in Tbilisi, Georgia. Between 1991-2005 B. Chankvetadze held research and teaching positions at the Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Germany and at the Department of Applied Chemistry, Graduate School of Engineering, Nagoya University, Japan.

B. Chankvetadze has published over 250 research papers in peer reviewed journals, over 30 review papers and book chapters and holds several patents of the former Soviet Union, USA, Germany and Japan. B. Chankvetadze has published one monograph (Capillary Electrophoresis in Chiral Analysis, Wiley&Sons, Chichester, UK, 1997), co-authored one book (Quantitative Determination of Antiepileptic Drugs in Biological Fluids, Tbilisi University Press, Tbilisi, Georgia, 1993) and edited one multiautored book (Chiral Separations, Elsevier Science, 2001). He has edited and co-edited many special issues of the journals Journal of Chromatography A, Journal of Chromatography O, Electrophoresis, Journal of Pharmaceutical and Biomedical Analysis and Journal of Separation Science on various topics of separation science.

B. Chankvetadze has given over 300 presentations as plenary, invited or oral speaker on the international conferences in fields of chirality, electromigration techniques and separation science. Together with editing the Journal of Pharmaceutical and Biomedical Analysis (Elsevier, Amsterdam, Netherlands) B. Chankvetadze is a member of the editorial boards of:

Electrophoresis (Wiley-VCH)

Journal of Chromatography A (Elsevier)

Journal of Chromatography O (Elsevier)

Journal of Separation Science (Wiley-VCH)

Chirality (Wiley)

Acta Chromatographica (Academia Kiado)

and several other international journals.

B. Chankvetadze is the recipient of “Journal of Chromatography Top Cited Article Awards” in 2005, 2006 and 2010, the recipient of “2006 Belgian Society of Pharmaceutical Science Award of Recognition” and and Csaba Horvath Memorial Award of the Hungarian Chemical Society and Connecticut Separation Science Council (USA) (2017).

Prof. B. Chankvetadze is Full Member of the Georgian National Academy of Sciences.

Pharmaceutical Analytical Chemistry, Analytical Chemistry, Bioassays, Instrumental Methods, Separation Science
İlkay Erdoğan Orhan
Prof. Dr. İlkay ERDOĞAN ORHAN LOKMAN HEKİM ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ

Prof. Dr. İlkay Erdoğan Orhan, Gazi Üniversitesi'nden (Ankara, Türkiye) Eczacı derecesine (1993), aynı Fakültenin Farmakognozi Anabilim Dalı'ndan 1. Yüksek Lisans derecesine (1996) Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (TÜBİTAK) tarafından sağlanan genç bilim insanı bursu ile sahiptir. Ardından, 1998 yılında Japonya'daki Ryukyus Üniversitesi'nde Monbusho bursu ile Deniz Doğal Ürün Kimyası alanında ikinci yüksek lisans derecesini aldı. Doktora derecesini 2002 yılında Gazi Üniversitesi Eczacılık Fakültesi'nde (Ankara, Türkiye) Farmakognozi alanında aldı. NATO-TUBITAK burs programı kapsamında 2003 yılında Winnipeg Üniversitesi (Kanada) Kimya Bölümü'nde doktora sonrası araştırmacı olarak bulundu. Yükseköğretim Kurulu (Türkiye) tarafından 2004 yılında Doçentliğe, 2009 yılında ise Profesörlüğe yükseltildi. Dr. Orhan, 2011-2014 yılları arasında Kuzey Kıbrıs'ta Doğu Akdeniz Üniversitesi Eczacılık Fakültesi Dekanlığı ve 2016-2024 yılları arasında Ankara'da Gazi Üniversitesi Eczacılık Fakültesi Dekanlığı görevlerini yürütmüştür. Dr. Orhan, Temmuz 2024'ten bu yana Lokman Hekim Üniversitesi Eczacılık Fakültesi Dekanı olarak görev yapmaktadır. Avusturya İlaç Araştırma Enstitüsü'nün (ADSI) Uluslararası Bilimsel Değerlendirme Kurulu Başkan Yardımcısıdır.

Dr. Orhan, Genç Kadın Dr. Orhan, OWSD (Gelişmekte Olan Ülkelerde Bilim Kadınları Örgütü) & Elsevier tarafından Asya kıtasında Genç Kadın Bilim İnsanı Ödülü, 2010 yılında COMSTECH (İİT Bilim ve Teknolojik İşbirliği Daimi Komitesi) tarafından Biyoloji alanında Bilim Ödülü, 2011 yılında L'Oreal & Türkiye Bilimler Akademisi tarafından Genç Kadın Bilim İnsanı Ödülü (Yaşam Bilimleri alanında) ve 2011 yılında Gazi Üniversitesi tarafından Onur Ödülü gibi çeşitli ödüller almıştır, 2015'te Türkiye'de Kadın İnovasyon Ödülü, 2016'da Türk Eczacıları Birliği tarafından Bilim Ödülü, 2017'de Eczacılık alanında Altın Havan Bilim Ödülü, 2017'de T.C. Bilim ve Teknoloji Bakanlığı tarafından Uluslararası Buluş Fuarı'nda Patent Gümüş Madalyası ve 2018'de Uluslararası Buluş Dernekleri Federasyonu (IFIA) tarafından En İyi Akademik Buluş Madalyası. Ayrıca 2024 yılında TWAS (Dünya Bilimler Akademisi) Kimya Bilim Ödülü ve Türk Sanayici ve İşadamları Vakfı (TÜSİAV) Üstün Hizmet ve Başarı Belgesi ile Türkiye Vegan ve Sağlıklı Yaşam Turizm Derneği (TEVSAD) & Türk Sanayici ve İşadamları Vakfı (TÜSİAV) & Çevre ve Şehircilik Bakanlığı İklim Elçisi Ödülü'nü almıştır. Türkiye Bilimler Akademisi (TÜBA) asli üyesidir ve 2019-2023 yılları arasında Avrupa Fitokimya Derneği (PSE) Güneydoğu Avrupa ve Türkiye Bölge Temsilciliği görevini yürütmüştür.

SCI-E tarafından listelenen 303 adet bilimsel makalenin, diğer bilimsel dergilerde 47 makalenin, 24 kitap bölümünün, 4 patentin (Türk, ABD ve EP), 6 patent başvurusunun ve 4 kitabın yazarıdır. H indeksi 57 (Web of Science) ve 63 (SCOPUS) olup 17000'den fazla atıf almıştır. Araştırma alanları doğal ürünlerin kimyası ve biyoaktiviteleri, doğal kozmetikler, fitoterapi, spor eczacılığı ve aromaterapidir. Halen Phytomedicine dergisinde Yardımcı Editör olarak görev yapmaktadır.

Plant Biotechnology, Ethobotany, Pharmacology and Pharmaceutical Sciences, Pharmacognosy, Pharmaceutical Botany
Default avatar
Prof. Dr. Bengi USLU ANKARA ÜNİVERSİTESİ
Electroanalytical Chemistry, Sensor Technology, Separation Science
Default avatar
Prof. Dr. Valentina UİVAROSİ Carol Davila University of Medicine and Pharmacy
Pharmaceutical Sciences, Bioinorganic Chemistry
Pharmacology and Pharmaceutical Sciences

Editorial Board

Selen Yeğenoğlu
Prof. Dr. Selen YEĞENOĞLU Hacettepe Üniversitesi
Pharmacology and Pharmaceutical Sciences, Pharmacy Management, Health Economy, Organizasyon, Strategy
Default avatar
Assoc. Prof. Dr. Yağmur AKDAĞ ÇAYLI HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmaceutical Delivery Technologies
Default avatar
Assoc. Prof. Dr. Merve DENİZALTI HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ, ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ, FARMAKOLOJİ ANABİLİM DALI
Basic Pharmacology
Default avatar
Prof. Dr. Miyase Gözde GÜNDÜZ HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmaceutical Chemistry
Default avatar
Assoc. Prof. Ayşegül DOĞAN HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmacology and Pharmaceutical Sciences, Pharmaceutical Analytical Chemistry, Analytical Chemistry, Health Sciences
Default avatar
Assoc. Prof. Dr. Kevser BIBEROGLU HACETTEPE UNIVERSITY, FACULTY OF PHARMACY
Enzymes, Pharmacology and Pharmaceutical Sciences, Pharmaceutical Biochemistry
Default avatar
Assoc. Prof. Dr. Bilge SÖZEN ŞAHNE HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmacology and Pharmaceutical Sciences, Pharmacy Management
Fatma Pınar Türkmenoglu
Prof. Dr. Fatma Pınar TÜRKMENOGLU HACETTEPE ÜNİVERSİTESİ
Pharmaceutical Botany
Default avatar
Assoc. Prof. Dr. Nadire ÖZENVER HACETTEPE UNIVERSITY, FACULTY OF PHARMACY
Pharmacognosy
Default avatar
Assoc. Prof. Dr. Suat SARI HACETTEPE UNIVERSITY

1981 yılında İzmir, Karaburun'da doğmuş olan Suat Sarı, lisans eğitimini 2004 yılında İstanbul Üniversitesi Eczacılık Fakültesinde tamamlayarak eczacı olarak mezun oldu. İnönü Üniversitesi Sağlık Bilimleri Enstitüsünde Farmasötik Kimya alanında yüksek lisans yaparak 2012 yılında Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsünde doktora eğitimine başladı. Bu esnada Hacettepe Üniversitesi Eczacılık Fakültesi Farmasötik Kimya Anabilim Dalında araştırma görevlisi olarak görev yapmaya başladı. Doktora çalışmalarını 2018 yılında tamamlayan Suat Sarı, 2020 yılında aynı anabilim dalına doktor öğretim üyesi olarak atandı ve 2023 yılında doçentlik ünvanı aldı. Çalışmalarını antifungal etkili azol türevi bileşiklerin tasarımı, bilgisayar destekli ilaç tasarımı ve organik sentetik medisinal kimya alanlarında yoğunlaştıran Suat Sarı evli ve bir çocuk babasıdır.

Pharmacology and Pharmaceutical Sciences, Pharmaceutical Chemistry
Zeynep Doğan
Asst. Prof. Dr. Zeynep DOĞAN HACETTEPE UNIVERSITY
Pharmacognosy
Default avatar
Prof. Dr. Suna ERDOĞAN HACETTEPE ÜNİVERSİTESİ
Pharmaceutical Delivery Technologies, Radiopharmacy
Default avatar
Res. Assist. Ahmet AVCI HACETTEPE UNIVERSITY
Pharmaceutical Chemistry
Elif Tugce Sarcan
Asst. Prof. Dr. Elif Tugce SARCAN HACETTEPE UNIVERSITY, FACULTY OF PHARMACY
Pharmaceutical Delivery Technologies, Radiopharmacy
Default avatar
Assoc. Prof. Gokcen TELLI HACETTEPE UNIVERSITY, FACULTY OF PHARMACY
Clinical Pharmacology and Therapeutics, Basic Pharmacology
Default avatar
Prof. Dr. R. Neslihan GÜRSOY HACETTEPE ÜNİVERSİTESİ
Pharmacology and Pharmaceutical Sciences, Pharmaceutical Sciences, Nanomedicine
Default avatar
Prof. Dr. İncilay SÜSLÜ Hacettepe Üniversitesi
Pharmaceutical Analytical Chemistry, Electroanalytical Chemistry, Instrumental Methods
Default avatar
Asst. Prof. Dr. Burcu KELLECİ ÇAKIR HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ

Burcu Kelleci Çakır, 2014 yılında Hacettepe Üniversitesi, Eczacılık Fakültesi’nden mezun olmuş ve aynı fakültenin Klinik Eczacılık Anabilim Dalı’nda lisansüstü çalışmalarına başlamıştır. Prof. Dr. Kutay Demirkan’ın danışmanlığında, 2017 yılında yüksek lisansını, Doç. Dr. Aygin Ekincioğlu’nun danışmanlığında 2023 yılında doktorasını tamamlamıştır. Lisans eğitiminin 1 yılını Slovenya’nın Ljublana şehrinde bulunan Eczacılık Fakültesinde, lisansüstü eğitimi sırasında ise 4 ay süre ile Almanya’nın Aachen şehrinde Uniclinik Aachen Üniversitesi Hastanesi Kardiyovasküler Cerrahi Anabilim Dalı’nda gözlemci araştırmacı olarak bulunmuştur.

Clinical Nutrition, Pharmaceutical Sciences, Clinical Pharmacy and Pharmacy Practice
Default avatar
Assoc. Prof. Dr. Selin Seda TİMUR HACETTEPE UNIVERSITY, FACULTY OF PHARMACY
Pharmaceutical Delivery Technologies
Pharmaceutical Toxicology
Default avatar
Prof. Dr. Gözde GİRGİN HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Pharmaceutical Toxicology
Emirhan Nemutlu
Prof. Dr. Emirhan NEMUTLU HACETTEPE ÜNİVERSİTESİ

Prof. Dr. Emirhan Nemutlu, 1998 yılında Hacettepe Üniversitesi Eczacılık Fakültesi’nden mezun olmuştur. Dr. Nemutlu, Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü Analitik Kimya Doktora programını 2008’de tamamlamıştır. Dr. Nemutlu 2006’da İspanya Barselona Üniversitesi’nde ve 2009-2012 arasında Amerika Birleşik Devletleri Mayo Klinik’te doktora sonrası çalışmalarda bulunmuştur. Dr. Nemutlu’nun 137’si SCI kapsamlı dergilerde olmak üzere 146 yayını ve altı kitap bölümü bulunmaktadır. Dr. Nemutlu’nun uluslararası ve ulusal kongrelerde sunulmuş 150’in üzerinde bildirisi bulunmaktadır. Dr. Nemutlu, 70’in üzerinde TÜBİTAK, TÜSEB ve Yüksek Öğrenim projelerinde araştırmacı/yürütücü olarak yer almıştır. Çeşitli poster ve sunum ödülleri yanı sıra Dr. Nemutlu, 2014 yılında Türkiye Eczacılar Birliği Akademisi Teşvik Ödülü’nü ve 2016’da Hacettepe Üniversitesi Teşvik Ödülü’nü almıştır.
Dr. Nemutlu, Hacettepe Üniversitesine bağlı merkezlerin (Klinik Araştırmalar Merkezi ve Transgenik Hayvan Teknolojileri) ve laboratuvarların (Hacettepe Üniversitesi İlaç ve Kozmetik Ar-Ge Laboratuvarı-HÜNİKAL, Aşı Ar-Ge Laboratuvarı ve Biyoanalitik ve Omiks Laboratuvarı) kurucu üyesidir.
Dr. Nemutlu, ilaç analizleri için yöntem geliştirme ve geçerlilik çalışmalarının yanı sıra, son yıllarda büyük önem kazanmış olan hastalığın teşhis ve tedavisine yönelik önemli bilgilerin ve biyobelirteçlerin elde edildiği multi-omik analizler arasında yer alan proteomik, metabolomik, lipidomik ve fluksomik çalışmalar yer almaktadır. Evli ve iki çocuk babası olan Dr. Nemutlu, Türkiye Doping Kontrol Merkezi Müdürü olarak çalışmalarını sürdürmektedir. 

Pharmaceutical Analytical Chemistry, Analytical Chemistry, Instrumental Methods
Default avatar
Prof. Dr. Mutlu AYTEMİR HACETTEPE ÜNİVERSİTESİ
Pharmaceutical Chemistry
Default avatar
Prof. Dr. Rahime ŞİMŞEK HACETTEPE UNIVERSITY
Pharmacology and Pharmaceutical Sciences, Pharmaceutical Chemistry, Basic Pharmacology
Default avatar
Prof. Dr. Ayşe ERCAN HACETTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
Biochemistry and Cell Biology, Enzymes, Genotoxicity and Cytotoxicity, Pharmacology and Pharmaceutical Sciences